Meeting
2018 Gastrointestinal Cancers Symposium
Time to adjuvant chemotherapy in CEA-positive colon cancer: An NCDB analysis.
Authors
Yang Zhang
Creighton University, Omaha, NE
Yang Zhang , Sarah J Aurit , Mohan Satish , Eugene Chau , Peter T. Silberstein
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 603)
DOI
10.1200/JCO.2018.36.4_suppl.603
Abstract #
603
Poster Bd #
C8
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Survival of stage III colon cancer patients with adjuvant chemotherapy: Experience from a specialized cancer institute in Latinoamerica-Peru.
First Author: Eder Christian Veramendi Cabana
Poster
2019 Gastrointestinal Cancers Symposium
Outcomes and utilization of adjuvant chemotherapy (AT) for stage II colon cancer (CC-II) in elderly population.
First Author: Afsaneh Barzi
Poster
2019 Gastrointestinal Cancers Symposium
Surgery versus surgery with adjuvant radiotherapy for T4 colon cancer.
First Author: Nikhil Sebastian
Poster
2017 Gastrointestinal Cancers Symposium
Association of delayed commencement of adjuvant chemotherapy (AC) with inferior survival in colon cancer patients with stage II and III diseases: A national population-based cohort study.
First Author: Ik Yong Kim